Elzanor 5/500mg Tablet 30s

Empagliflozin 5mg and Metformin Hydrochloride 500mg constitute a fixed-dose combination medication utilized for the treatment of type 2 diabetes. Empagliflozin acts by inhibiting glucose reuptake in the kidneys, leading to heightened glucose excretion in urine, thereby reducing blood sugar levels. It also positively influences insulin sensitivity, diminishes endogenous glucose production, and contributes to weight loss, while simultaneously mitigating cardiovascular mortality risks in adults with type 2 diabetes prone to cardiovascular death.